More than 80companies currently claim to offer manufacturing related services, at differentscales of operations, for a variety of oligonucleotide-based products

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs

The rapidly growing demand for oligonucleotides,coupled to complex manufacturing procedures and high capital investmentsrequired for setting up manufacturing facilities, has generated a range of newopportunities for custom manufacturers

A detailed assessment of the current market landscape, including information on drug developer(s),

Roots Analysis has done a detailedstudy PatientRecruitment and Retention Services Marker, 2019-2030.”

A steadily increasingdemand for participants in clinical research studies, coupled to thecomplexities associated with patient enrolment, have prompted drug / therapydevelopers to outsource this process to specialty service providers

A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications. It features information on the year of establishment

Severalbig pharma companies are known to outsource more than half of their clinical-stageoligonucleotide manufacturing operations.

Over time, manypharma companies have begun incorporating augmented reality (AR) and virtualreality (VR) features, in order to offer an experiential and interactivedimension to their educational / marketing content

Given the presentscenario, many stakeholders are adopting such advanced marketing strategies todrive better consumer engagement through the use of immersive and interactivetechnologies

An analysis of the most commonly targeted therapeutic indications and details of ADC candidates being developed against them, highlighting key epidemiological facts about the diseases and currently available treatment options, other than ADCs.

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to ef...

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.

Antibody drugconjugates (ADCs) represent a transformative approach to modern cancertreatment; over the years, this upcoming class of targeted therapeutic agentshas generated significant enthusiasm within the medical science community

Roots Analysis has done a detailedstudy on DrugRepurposing Service Providers Market, 2020-2030.” coveringkey aspects of the industry’s evolution and identifying potential future growthopportunities.